Sermorelin, explained.
Research, safety questions, and treatment context.
The form
More than one catalog form
The routine
Research has used scheduled injections, but the appropriate frequency, monitoring and tablet absorption need review for the exact formulation.
The evidence
Small human studies · wellness outcomes uncertain
Forms listed in a June 2025 catalog. Current availability and individual instructions need confirmation.
On this page
A linked source is not a clinical endorsement. How we handle review and corrections.
- Legal status
- Compoundable now
Compoundable today with a prescription. It was an FDA-approved drug, Geref, until its maker stopped selling it in 2008 for business reasons.
- At Goodmorrow
- Offered when we open
What it is
Sermorelin is the first 29 amino acids of growth hormone releasing hormone, the signal your brain uses to tell the pituitary to release growth hormone. It was sold as an FDA-approved drug called Geref until 2008, when the manufacturer discontinued it for commercial reasons.
What the evidence shows
Sermorelin reliably raises growth hormone and IGF-1 in people with a working pituitary. Evidence that it improves body composition, sleep or recovery in healthy adults is limited to small studies and clinical experience.
How Goodmorrow handles it
We check IGF-1 before and during treatment, so your dose is set by your numbers rather than a template. It's usually a small injection at night.
Before you take it
- Not for anyone with active cancer or who is pregnant. Common side effects are injection-site redness, flushing and headache.
Questions people ask
Is sermorelin the same as HGH?
No. HGH is growth hormone itself. Sermorelin asks your own pituitary to make more, which keeps your body's normal feedback in place.
Sermorelin or CJC-1295 and ipamorelin?
They work on the same pathway. The difference that matters today is that sermorelin is lawful to compound and the other two aren't.
Sources
- Secondary sourceThe US Peptide Status Index Peptide America
- Secondary sourceThe Peptide Reclassification Everyone's Talking About: A Pharmacist's Take Pharmacy Times, 2026
Good days ahead.
Join the opening list for appointment updates.